Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing for autoimmunity in humans.

David D'Cruz1

  • 1The Lupus Research Unit, St. Thomas' Hospital, SE1 7EH, London, UK. david.d'cruz@kcl.ac.uk

Toxicology Letters
|June 8, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Two-year follow-up of neuropsychiatric symptoms in patients with systemic autoimmune rheumatic diseases: longitudinal insights on depression, anxiety, memory and adaptation in the INSPIRE cohort.

EClinicalMedicine·2026
Same author

Bringing back 'significance' to MGUS.

Rheumatology (Oxford, England)·2026
Same author

A randomised open-label pilot trial comparing mycophenolate mofetil with no immunosuppression in limited cutaneous systemic sclerosis (MINIMISE-Pilot).

Rheumatology (Oxford, England)·2026
Same author

Patient satisfaction and experiences with menopause care for people with autoimmune diseases: an international mixed-methods study from the Menopause MATTERs Project.

Maturitas·2025
Same author

Adapting to living with systemic autoimmune rheumatic diseases; a qualitative exploration of patient and clinician perspectives.

Rheumatology international·2025
Same author

'<i>If I Were White</i>': a qualitative analysis of the experiences of minoritized ethnic groups with systemic autoimmune rheumatic diseases in the United Kingdom.

Ethnicity & health·2025
Same journal

LEF1 regulated CTHRC1 Promotes Silica-Induced Pulmonary Fibrosis through CD44-Dependent Signaling.

Toxicology letters·2026
Same journal

hERG Channel Blockade and Additive Interactions of Magnolol and Honokiol from Magnolia Species.

Toxicology letters·2026
Same journal

Evaluation of dose-dependent hematotoxic effects of celastrol on human blood cells in vitro.

Toxicology letters·2026
Same journal

Environmental pharmaceutical and antibiotic mixtures: An exposomics-guided framework for mechanistic toxicology.

Toxicology letters·2026
Same journal

Size- and morphology-dependent cytotoxicity of metal-organic frameworks: Deciphering the structure-toxicity relationship.

Toxicology letters·2026
Same journal

Steroidogenesis suppression in H295R cells by 1,3-disubstituted ureas: A potential off-target effect of some sEH inhibitors.

Toxicology letters·2026
See all related articles

Environmental factors can trigger autoimmune rheumatic diseases, making diagnosis challenging. Autoantibody markers, alongside clinical features, significantly aid in early and accurate diagnosis of these conditions.

Area of Science:

  • Rheumatology
  • Immunology
  • Environmental Medicine

Background:

  • Autoimmune rheumatic diseases (AIRDs) are linked to environmental exposures, including drugs and chemicals.
  • Non-specific symptoms often complicate the early diagnosis of AIRDs.
  • Serological markers, specifically autoantibodies, are crucial for improving diagnostic accuracy.

Purpose of the Study:

  • To review major autoimmune rheumatic diseases.
  • To highlight associated autoantibody markers for diagnostic improvement.

Main Methods:

  • Literature review of autoimmune rheumatic diseases.
  • Focus on diagnostic utility of autoantibody markers.

Main Results:

  • Environmental factors are implicated in the etiology of several AIRDs.

Related Experiment Videos

  • Autoantibodies serve as key biomarkers in conjunction with clinical presentation.
  • Diagnostic capabilities are enhanced by integrating autoantibody data with patient symptoms.

    • Conclusions:

    • Autoantibody testing is vital for the diagnosis of autoimmune rheumatic diseases.
    • Understanding environmental triggers and serological markers improves patient outcomes.